As of 4:00pm ET
| +0.18 / +1.49%|
The 5 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 17.00, with a high estimate of 17.00 and a low estimate of 15.00. The median estimate represents a +38.55% increase from the last price of 12.27.
The current consensus among 6 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.